Navigation Links
Clear rules needed to govern deep sea bioprospecting: UNU

Vast genetic resources ?"blue gold" on the international deep sea floor ?need protection from unfettered commercial exploitation, warns a new report from the Japan-based United Nations University Institute for Advanced Studies (UNU-IAS).

Increasingly recognized as important to humankind for their potential medical and other uses, deep sea resources are now more accessible and vulnerable than ever because of rapid advances in exploration technology, the report says.

Known as "extremophiles," the genetic make-up of organisms of the deep that live in extreme conditions of pressure, temperature and toxicity is drawing enormous interest from scientists and companies bioprospecting for possible pharmaceutical or industrial applications. Already several valuable products have been created and there is growing recognition of the potential of deep sea genes to advance human welfare.

The new report, Bioprospecting of Genetic Resources in the Deep Seabed (online at http://www.ias.unu.edu/binaries2/DeepSeabed_FINAL.pdf), cites rising concern about the absence of clear rules governing access to and the sharing of benefits derived from the "global commons" of the sea beds and about the potential for severe, perhaps permanent damage to these unique and sensitive ecosystems, which include seamounts, cold seeps and hydrothermal vents ?the latter considered nurseries for life on Earth.

"Deep sea ecosystems hold the promise of huge potential contributions to future human well-being, provide our planet with vital climate-related and other ecological services, and have much to teach us about life processes," says UNU-IAS Director A.H. Zakri.

"The unfettered and unregulated exploitation of international sea beds and the organisms living there could have serious long-term consequences for humankind," he says. "And for the private sector, uncertainty caused by the absence of clear, globally-agreed rules deters important research and investment decisio
'"/>

Source:United Nations University


Page: 1 2 3 4 5

Related biology news :

1. FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain
2. Clearing jams in copy machinery
3. Researchers create functioning artificial proteins using natures rules
4. Study: Paramedics save more lives when they dont follow the rules
5. Scientists uncover rules for gene amplification
6. A much-needed shot in the arm for HIV vaccine development
7. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
8. Quick identification needed to save Floridas citrus industry from devastating disease
9. Womb needed for proper brain development
10. Molecular research suggest shift needed in how some drugs are created
11. Gene needed for butterfly transformation also key for insects like grasshoppers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clear rules needed govern deep sea bioprospecting UNU

(Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik ... und findet vom 22. bis 25. Oktober 2015 ... Die Konferenz feiert in diesem ... ist die ICG weltweit zu einem der einflussreichsten ... eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4
... year since their 2008 preliminary ranking, Cell Press journals Cell ... their Impact Factors surge, according to new data released in the ... released June 17, Cell Stem Cell ,s rating rose to ... Cell Host and Microbe ranks 13.021 - boasting an ...
... Two researchers from the University of Santiago de Compostela ... antisocial behaviour. The results show that the principal goal ... leave home. The most antisocial among them place greater ... teenagers place most importance on are to do with ...
... currently being undertaken at the University of Leicester may ... Aneurysms (AAA) in men. In her doctoral study, ... causes of the male predominance of AAA, with a ... results from the study will be showcased at the ...
Cached Biology News:New 2009 Impact Factors soar for newest Cell Press journals 2Teenagers want to finish their studies and leave home 2Increased likelihood of male death from disease 2
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation ... largest providers of post-acute healthcare services, offering both ... results of operations for the second quarter ended ... was characterized by strong volume growth in both ... EBITDA," said Jay Grinney, President and Chief Executive ...
(Date:7/29/2015)... Research and Markets ... the "Global Biosimilars Market, 2015 - 2025" ... Global Biosimilars Market, 2015 - 2025, report provides ... market. With the blockbuster biologics losing patent protection ... are being viewed as viable substitutes to the ...
(Date:7/29/2015)... , July 29, 2015  Therapath Neuropathology ... announces increased partnerships with VA and Military Medical ... Nerve Fiber Density (ENFD) and Sweat Gland Nerve ... fiber neuropathy ( https://therapath.com/skin ). ... Fiber Density (ENFD) on punch skin biopsy is ...
(Date:7/29/2015)... ... ... The third Medical Innovation Impact Index (MI3) Alert considers FDA processes for ... current system received a score of 0 (range -10 to +10) for its impact ... Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation and Entrepreneurship. Several changes ...
Breaking Biology Technology:HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27HealthSouth Reports Results for Second Quarter 2015 28HealthSouth Reports Results for Second Quarter 2015 29HealthSouth Reports Results for Second Quarter 2015 30HealthSouth Reports Results for Second Quarter 2015 31HealthSouth Reports Results for Second Quarter 2015 32HealthSouth Reports Results for Second Quarter 2015 33HealthSouth Reports Results for Second Quarter 2015 34HealthSouth Reports Results for Second Quarter 2015 35HealthSouth Reports Results for Second Quarter 2015 36
... PXS, Nasdaq: PXSL) today announced that its Phase ... people with bronchiectasis has met its two,primary efficacy ... Data from the 362 subject study demonstrated a ... weeks of treatment with Bronchitol,as assessed by the ...
... ... - Company ... BioPharma, Inc.,(PDL) (Nasdaq: PDLI ) today announced a significant strategic ... antibodies in,oncology and select immunological diseases, following a months-long,business and portfolio ...
... - Plan Extends Financial Resources Beyond 2008 -, ... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... percent, and implementing a revised,operating plan that focuses ... programs while streamlining the company,s operations and extending,its ...
Cached Biology Technology:Phase III Trial Finds Pharmaxis' Bronchitol Effective 2Phase III Trial Finds Pharmaxis' Bronchitol Effective 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 4PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 5Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 2Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 3Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 4
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
Weinreb Linker...
Anti-Human Factor XIII HRPO (Polyclonal) (sheep IgG)...
Request Info...
Biology Products: